March 30, 2016
The IL-17 inhibitor Taltz (ixekizumab) from Eli Lilly is approved for adults with plaque psoriasis. Venus Concepts' Venus Versa is cleared for multiple aesthetic indications. Strata Sciences gets FDA clearance for new "Classifier Code" for use with MelaFind. Vitals.com shows that wait times are going down. But beware, patients who wait 20 minutes or more are more likely to post negative reviews. And controversial research suggests that patients who sunbathe have lower rates of heart related and non-cancer/non-heart disease related deaths. Could vitamin D play a role?